betaine has been researched along with Chronic Kidney Diseases in 11 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some studies on CKD animal models have shown the benefits of betaine supplementation, including decreased kidney damage, antioxidant recovery status, and decreased inflammation." | 5.22 | The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review. ( Alvarenga, L; Ferreira, MS; Kemp, JA; Mafra, D, 2022) |
| "Hyperhomocysteinemia has undoubtedly a central role in such a prominent cardiovascular burden." | 2.66 | Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery. ( Bergamini, C; Capelli, I; Cappuccilli, M; Cianciolo, G; Conte, D; Donati, G; Giacomelli, FA; La Manna, G; Natali, T, 2020) |
| "In end-stage renal disease (ESRD), these same small molecules are used to determine dialysis dose and dialytic clearance." | 1.51 | Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function. ( Garg, AX; House, AA; Lajoie, GA; Mio, MA; RaoPeters, AAE; Thomson, BKA; Tonial, NC; Urquhart, BL; Velenosi, TJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 7 (63.64) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, JA | 1 |
| Jewell, DE | 2 |
| Ephraim, E | 2 |
| Alvarenga, L | 1 |
| Ferreira, MS | 1 |
| Kemp, JA | 1 |
| Mafra, D | 1 |
| Kwan, B | 1 |
| Fuhrer, T | 1 |
| Montemayor, D | 1 |
| Fink, JC | 1 |
| He, J | 1 |
| Hsu, CY | 1 |
| Messer, K | 1 |
| Nelson, RG | 1 |
| Pu, M | 1 |
| Ricardo, AC | 1 |
| Rincon-Choles, H | 1 |
| Shah, VO | 1 |
| Ye, H | 1 |
| Zhang, J | 1 |
| Sharma, K | 1 |
| Natarajan, L | 1 |
| Pelletier, CC | 1 |
| Croyal, M | 1 |
| Ene, L | 1 |
| Aguesse, A | 1 |
| Billon-Crossouard, S | 1 |
| Krempf, M | 1 |
| Lemoine, S | 1 |
| Guebre-Egziabher, F | 1 |
| Juillard, L | 1 |
| Soulage, CO | 1 |
| Cappuccilli, M | 1 |
| Bergamini, C | 1 |
| Giacomelli, FA | 1 |
| Cianciolo, G | 1 |
| Donati, G | 1 |
| Conte, D | 1 |
| Natali, T | 1 |
| La Manna, G | 1 |
| Capelli, I | 1 |
| Guo, F | 1 |
| Dai, Q | 1 |
| Zeng, X | 1 |
| Liu, Y | 1 |
| Tan, Z | 1 |
| Zhang, H | 1 |
| Ouyang, D | 1 |
| Ebert, T | 1 |
| Painer, J | 1 |
| Bergman, P | 2 |
| Qureshi, AR | 2 |
| Giroud, S | 1 |
| Stalder, G | 1 |
| Kublickiene, K | 1 |
| Göritz, F | 1 |
| Vetter, S | 1 |
| Bieber, C | 1 |
| Fröbert, O | 1 |
| Arnemo, JM | 1 |
| Zedrosser, A | 1 |
| Redtenbacher, I | 1 |
| Shiels, PG | 1 |
| Johnson, RJ | 1 |
| Stenvinkel, P | 2 |
| Xu, KY | 1 |
| Xia, GH | 1 |
| Lu, JQ | 1 |
| Chen, MX | 1 |
| Zhen, X | 1 |
| Wang, S | 1 |
| You, C | 1 |
| Nie, J | 1 |
| Zhou, HW | 1 |
| Yin, J | 1 |
| Velenosi, TJ | 1 |
| Thomson, BKA | 1 |
| Tonial, NC | 1 |
| RaoPeters, AAE | 1 |
| Mio, MA | 1 |
| Lajoie, GA | 1 |
| Garg, AX | 1 |
| House, AA | 1 |
| Urquhart, BL | 1 |
| Missailidis, C | 1 |
| Hällqvist, J | 1 |
| Barany, P | 1 |
| Heimbürger, O | 1 |
| Lindholm, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD): a Open Label, Multicenter Trial[NCT05838118] | 100 participants (Anticipated) | Interventional | 2023-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for betaine and Chronic Kidney Diseases
| Article | Year |
|---|---|
The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review.
Topics: Animals; Antioxidants; Betaine; Dysbiosis; Humans; Inflammation; Renal Insufficiency, Chronic | 2022 |
Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.
Topics: Betaine; Cardiovascular Diseases; Choline; Dietary Supplements; DNA Methylation; Eating; Epigenesis, | 2020 |
1 trial available for betaine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Betaine and Soluble Fiber Improve Body Composition and Plasma Metabolites in Cats with Chronic Kidney Disease.
Topics: Animals; Betaine; Body Composition; Cats; Dietary Supplements; Metabolome; Renal Insufficiency, Chro | 2023 |
8 other studies available for betaine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Feeding cats with chronic kidney disease food supplemented with betaine and prebiotics increases total body mass and reduces uremic toxins.
Topics: Animals; Betaine; Body Weight; Cats; Cross-Over Studies; Feces; Prebiotics; Renal Insufficiency, Chr | 2022 |
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Topics: Algorithms; Betaine; Diabetes Mellitus; Diabetic Nephropathies; Humans; Metabolomics; Renal Insuffic | 2023 |
Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
Topics: Adult; Betaine; Choline; Creatinine; Female; Gastrointestinal Microbiome; Glomerular Filtration Rate | 2019 |
Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Topics: Betaine; Biomarkers; Carnitine; Choline; Female; Glomerular Filtration Rate; Humans; Kidney; Male; M | 2021 |
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears.
Topics: Adult; Aged; Aged, 80 and over; Animals; Betaine; Biomimetics; Cardiovascular Diseases; Choline; Fem | 2020 |
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Topics: Adult; Aged; Animals; Betaine; Carnitine; Case-Control Studies; Choline; Clostridiaceae; Dysbiosis; | 2017 |
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function.
Topics: Adult; Aged; Aged, 80 and over; Betaine; Biomarkers; Creatinine; Female; Glomerular Filtration Rate; | 2019 |
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Topics: Adult; Aged; Betaine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Choline; Female; Fibr | 2016 |